PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Dermatology, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.\', \'Department of Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA, jmaghfou@tulane.edu.\', \'Arizona College of Osteopathic Medicine, Midwestern University, Glendale, Arizona, USA.\', \'College of Medicine, SUNY Downstate Health Sciences Center, New York, New York, USA.\', \'School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.\', \'College of Osteopathic Medicine, Rocky Vista University, Parker, Colorado, USA.\', \'Rocky Mountain Regional Veterans Affairs Medical Center, Aurora, Colorado, USA.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1159/000518471
?:hasPublicationType
?:journal
  • Dermatology (Basel, Switzerland)
is ?:pmid of
?:pmid
?:pmid
  • 34511591
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Interferon and Toll-Like Receptor 7 Response in COVID-19: Implications of Topical Imiquimod for Prophylaxis and Treatment.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all